碱性磷酸酶在临床相关疾病认知障碍中的研究
Research on Alkaline Phosphatase in Cognitive Impairment of Clinical Related Diseases
DOI: 10.12677/ACM.2023.1351195, PDF,   
作者: 李 卓：青海大学研究生院，青海 西宁；刘 冀：青海大学附属医院老年医学科，青海 西宁
关键词: 认知障碍；碱性磷酸酶；临床相关疾病；Cognitive Impairment； Alkaline Phosphatase； Clinically Relevant Disease
摘要: 认知障碍的发病率随全球人口老龄化呈逐年升高趋势，其最严重可发展为痴呆，给个人及家庭带来了沉重的负担。碱性磷酸酶(ALP)作为人体内众多酶中的一种，发挥着强大的作用，同时它也是目前免疫诊断试剂产品最常用的标记酶之一，拥有稳定性高、灵敏度高等诸多优点。而近些年来，大量研究显示，ALP水平在认知障碍中也存在显著增高。本文就ALP的结构及生物学特性以及在临床相关性疾病认知障碍中作用的研究作一综述。
Abstract: The incidence of cognitive disorders increases year by year with the aging of the global population, and the most serious can develop into dementia, which brings a heavy burden to individuals and families. Alkaline phosphatase (ALP), as one of the many enzymes in human body, plays a powerful role. At the same time, ALP is also one of the most commonly used marker enzymes in immunodi-agnostic reagent products. It has many advantages, such as high stability and high sensitivity. In recent years, a large number of studies have shown that ALP level is also significantly increased in cognitive impairment. This review reviews the structure and biological characteristics of ALP and its role in cognitive impairment in clinically related diseases.
文章引用：李卓, 刘冀. 碱性磷酸酶在临床相关疾病认知障碍中的研究[J]. 临床医学进展, 2023, 13(5): 8541-8546. https://doi.org/10.12677/ACM.2023.1351195

参考文献

[1] 任盈盈. 高甘油三酯腰围表型与老年认知障碍的相关研究[D]: [硕士学位论文]. 济宁: 济宁医学院, 2022.[CrossRef] 
[2] Kealy, J., et al. (2020) Acute Inflammation Alters Brain Energy Metabolism in Mice and Humans: Role in Suppressed Spontaneous Activity, Impaired Cognition, and Delirium. The Journal of Neuroscience, 40, 5681-5696. [Google Scholar] [CrossRef] 
[3] Robison, R. (21923) The Possible Significance of Hex-osephosphoric Esters in Ossification. Biochemical Journal, 17, 286-293. [Google Scholar] [CrossRef] [PubMed]
[4] 肖婷. 碱性磷酸酶与脑小血管病患者认知功能的相关性研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2020.[CrossRef] 
[5] Millán, J.L. (1986) Molecular Cloning and Sequence Analysis of Human Placental Alkaline Phosphatase. The Journal of Biological Chemistry, 261, 3112-3115. [Google Scholar] [CrossRef] 
[6] Weiss, M.J., et al. (1986) Isolation and Characterization of a cDNA Encoding a Human Liver/Bone/Kidney-Type Alkaline Phosphatase. Proceedings of the National Academy of Sci-ences of the United States of America, 83, 7182-7186. [Google Scholar] [CrossRef] [PubMed]
[7] Millán, J.L. and Manes, T. (1988) Seminoma-Derived Nagao Iso-zyme Is Encoded by a Germ-Cell Alkaline Phosphatase Gene. Proceedings of the National Academy of Sciences of the United States of America, 85, 3024-3028. [Google Scholar] [CrossRef] [PubMed]
[8] Berger, J., Garattini, E., Hua, J.C. and Udenfriend, S. (1987) Cloning and Sequencing of Human Intestinal Alkaline Phosphatase cDNA. Proceedings of the National Academy of Sciences of the United States of America, 84, 695-698. [Google Scholar] [CrossRef] [PubMed]
[9] Buchet, R., Millán, J.L. and Magne, D. (2013) Multisystemic Functions of Alkaline Phosphatases. In: Millán, J., Ed., Phosphatase Modulators. Methods in Molecular Biology, Vol. 1053, Hu-mana Press, Totowa, 27-51. [Google Scholar] [CrossRef] [PubMed]
[10] Low, M.G. (1987) Biochemistry of the Glyco-syl-Phosphatidylinositol Membrane Protein Anchors. Biochemical Journal, 244, 1-13. [Google Scholar] [CrossRef] [PubMed]
[11] Gao, Y., et al. (2015) The Characteristic of Cognitive Function in Type 2 Diabetes Mellitus. Diabetes Research and Clinical Practice, 109, 299-305. [Google Scholar] [CrossRef] [PubMed]
[12] Xue, M., et al. (2019) Diabetes Mellitus and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 144 Prospective Studies. Ageing Research Re-views, 55, Article ID: 100944. [Google Scholar] [CrossRef] [PubMed]
[13] Simó, R., Ciudin, A., Simó-Servat, O. and Hernández, C. (2017) Cognitive Impairment and Dementia: A New Emerging Complication of Type 2 Diabetes—The Diabetologist’s Perspec-tive. Acta Diabetologica, 54, 417-424. [Google Scholar] [CrossRef] [PubMed]
[14] 孙琦. 西宁地区107例糖尿病患者血清碱性磷酸酶检测分析[J]. 检验医学与临床, 2010, 7(20): 2301-2302.
[15] 郭蓉, 吴立红, 周小芳, 王吉玉. 2型糖尿病患者血清碱性磷酸酶与血脂及胰岛素抵抗的相关性分析[J]. 中国乡村医药, 2013, 20(19): 23-25. [Google Scholar] [CrossRef] 
[16] 肖婷, 淦勤, 唐震宇, 黄小红. 碱性磷酸酶与脑小血管病患者认知功能的相关性研究碱性磷酸酶与脑小血管病患者认知功能的相关性研究[J]. 江西医药, 2022, 57(8): 907-911.
[17] Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Prac-tice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements, 7, 1-59. [Google Scholar] [CrossRef] [PubMed]
[18] Massy, Z. and Drueke, T. (2017) Adynamic Bone Disease Is a Predominant Bone Pattern in Early Stages of Chronic Kidney Disease. Journal of Nephrology, 30, 629-634. [Google Scholar] [CrossRef] [PubMed]
[19] 华青, 张敏芳, 李璐瑶. 骨特异性碱性磷酸酶在慢性肾脏病矿物质与骨代谢紊乱中的研究进展[J]. 中国中西医结合肾病杂志, 2018, 19(7): 647-649.
[20] Delanaye, P, Souber-bielle, J.-C., Lafage-Proust, M.-H., Jean, G. and Cavalier, E. (2014) Can We Use Circulating Biomarkers to Monitor Bone Turnover in CKD Haemodialysis Patients? Hypotheses and Facts. Nephrology Dialysis Transplantation, 29, 997-1004. [Google Scholar] [CrossRef] [PubMed]
[21] Bervoets, A.R.J., et al. (2003) Useful Biochemical Markers for Diagnosing Renal Osteodystrophy in Predialysis End- Stage Renal Failure Patients. American Journal of Kidney Dis-eases, 41, 997-1007. [Google Scholar] [CrossRef] 
[22] Kellett, K.A., Williams, J., Vardy, E.R., Smith, A.D. and Hooper, N.M. (2011) Plasma Alkaline Phosphatase is Elevated in Alzheimer’s Disease and Inversely Correlates with Cognitive Function. International Journal of Molecular Epidemiology and Genetics, 2, 114-121.
[23] Brichacek, A.L. and Brown, C.M. (2019) Alkaline Phosphatase: A Potential Biomarker for Stroke and Implications for Treatment. Meta-bolic Brain Disease, 34, 3-19. [Google Scholar] [CrossRef] [PubMed]
[24] Wardlaw, J.M., Smith, C. and Dichgans, M. (2013) Mechanisms of Sporadic Cerebral Small Vessel Disease: Insights from Neuroimaging. The Lancet Neurology, 12, 483-497. [Google Scholar] [CrossRef] 
[25] Wardlaw, J.M., et al. (2013) Neu-roimaging Standards for Research into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration. The Lancet Neurology, 12, 822-838. [Google Scholar] [CrossRef] 
[26] 张兵, 董瑞芳, 郄新稳, 田爽, 张超. 脑梗死合并缺血性脑白质病变患者危险因素的分析[J]中华老年心脑血管病杂志, 2017, 19(1): 67-69.
[27] Lee, H.-B., et al. (2015) Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease. PLOS ONE, 10, e0143355. [Google Scholar] [CrossRef] [PubMed]
[28] Langer, D., Ikehara, Y., Takebayashi, H., Hawkes, R. and Zimmermann, H. (2008) The Ectonucleotidases Alkaline Phosphatase and Nucleoside Triphosphate Diphosphohydrolase 2 Are Associated with Subsets of Progenitor Cell Populations in the Mouse Embry-onic, Postnatal and Adult Neurogenic Zones. Neuroscience, 150, 863-879. [Google Scholar] [CrossRef] [PubMed]
[29] Vardy, E.R.L.C., Kellett, K.A.B., Cocklin, S.L. and Hoop-er, N.M. (2012) Alkaline Phosphatase Is Increased in Both Brain and Plasma in Alzheimer’s Disease. Neurodegenera-tive Diseases, 9, 31-37. [Google Scholar] [CrossRef] [PubMed]
[30] 吴有丽, 沈春子, 周霞, 张宏, 游孟哲, 朱小群, 孙中武. 皮质下缺血性血管病患者血清碱性磷酸酶变化及其对认知功能的影响[J]. 中华神经科杂志, 2016, 49(11): 827-832.
[31] Li, J.-W., Xu, C., Fan, Y., Wang, Y. and Xiao, Y.-B. (2014) Can Serum Levels of Alkaline Phosphatase and Phosphate Predict Cardiovascular Diseases and Total Mortality in Individuals with Preserved Renal Function? A Systemic Review and Meta-Analysis. PLOS ONE, 9, e102276. [Google Scholar] [CrossRef] [PubMed]
[32] Kunutsor, S.K., et al. (2017) Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein. PLOS ONE, 10, e0132822. [Google Scholar] [CrossRef] [PubMed]
[33] Libby, P., Ridker, P. and Hansson, G. (2011) Progress and Challenges in Translating the Biology of Atherosclerosis. Nature, 473, 317-325. [Google Scholar] [CrossRef] [PubMed]
[34] Ndrepepa, G., et al. (2017) Prognostic Value of Alkaline Phosphatase in Patients with Acute Coronary Syndromes. Clinical Biochemistry, 50, 828-834. [Google Scholar] [CrossRef] [PubMed]
[35] Pattanshetty, D.J., Cook, D., et al. (2017) Heart Failure Pa-tients with Reduced Ejection Fraction Have Higher Prevalence of Cognitive Impairment Despite Normal MMSE. Journal of Cardiac Failure, 23, S68.
[36] 刘佳月, 冯玉宝. 心血管疾病与认知功能障碍筛查的研究进展[J]. 中国社区医师, 2022, 38(6): 7-9.
[37] Hung, H.-Y., et al. (2017) Preoperative Alkaline Phosphatase Elevation Was Associated with Poor Survival in Colorectal Cancer Patients. International Journal of Colorectal Disease, 32, 1775-1778. [Google Scholar] [CrossRef] [PubMed]
[38] Wei, X.-L., et al. (2016) The Predictive Value of Alkaline Phos-phatase and Lactate Dehydrogenase for Overall Survival in Patients with Esophageal Squamous Cell Carcinoma. Tumour Biology, 37, 1879-1887. [Google Scholar] [CrossRef] [PubMed]
[39] Xu, X.-S., et al. (2014) Model Based on γ-Glutamyltransferase and Alkaline Phosphatase for Hepatocellular Carcinoma Prognosis. World Journal of Gastroenterology, 20, 10944-10952. [Google Scholar] [CrossRef] [PubMed]
[40] Li, G., et al. (2012) Increased Pretreatment Levels of Serum LDH and ALP as Poor Prognostic Factors for Nasopharyngeal Carcinoma. Chinese Journal of Cancer, 31, 197-206. [Google Scholar] [CrossRef] [PubMed]
[41] Faloppi, L., et al. (2015) The Value of Lactate Dehydrogenase Serum Levels as a Prognostic and Predictive Factor for Advanced Pancreatic Cancer Patients Receiving Sorafenib. On-cotarget, 6, 35087-35094. [Google Scholar] [CrossRef] [PubMed]
[42] Kotb, M.G., et al. (2019) Chemotherapy-Induced Cognitive Impair-ment in Hematological Malignancies. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 55, Article No. 56. [Google Scholar] [CrossRef] 

为你推荐